List of insiders holdings for Blueprint Medicines Corp:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| FMR LLC See Remark 1 | 2024-02-09 08:35:54 | 4,348,311 0 | 4,348,311 | Form 13G |
| LEVIN MARK J 10% Owner | 2017-03-20 16:21:02 | 111,244 3,453,753 | 3,564,997 | Form 4 |
| Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner | 2019-02-13 16:04:32 | 1,022,165 0 | 1,022,165 | Form 13G |
| Kuvalanka Kyle D. Chief Business Officer | 2015-04-30 07:17:30 | 187,271 0 | 187,271 | Form 3 |
| Albers Jeffrey W. Director | 2024-03-26 21:11:07 | 165,017 0 | 165,017 | Form 4 |
| Haviland Kate CHIEF EXECUTIVE OFFICER | 2024-03-11 18:27:16 | 153,177 0 | 153,177 | Form 4 |
| LYNCH DANIEL Director | 2020-06-26 16:08:05 | 132,404 0 | 132,404 | Form 4 |
| Borisy Alexis Director | 2023-06-23 19:03:29 | 77,218 0 | 77,218 | Form 4 |
| Namouni Fouad PRESIDENT, R & D | 2024-03-11 18:20:04 | 72,703 0 | 72,703 | Form 4 |
| Rossi Christina CHIEF OPERATING OFFICER | 2024-03-11 18:21:14 | 64,306 0 | 64,306 | Form 4 |
| Lydon Nicholas Director | 2023-06-23 19:02:13 | 61,084 0 | 61,084 | Form 4 |
| McCain Tracey L EVP AND CHIEF LEGAL OFFICER | 2024-03-11 18:18:16 | 60,498 0 | 60,498 | Form 4 |
| Durso-Bumpus Debra CHIEF PEOPLE OFFICER | 2024-03-11 18:28:06 | 57,585 0 | 57,585 | Form 4 |
| Landsittel Michael CHIEF FINANCIAL OFFICER | 2024-04-01 16:34:52 | 57,286 0 | 57,286 | Form 4 |
| Lengauer Christoph Chief Scientific Officer | 2016-04-14 17:55:33 | 56,657 0 | 56,657 | Form 4 |
| Dorsch Marion Chief Scientific Officer | 2021-02-24 16:28:01 | 55,672 0 | 55,672 | Form 4 |
| Carter Percy H. CHIEF SCIENTIFIC OFFICER | 2024-03-11 18:19:09 | 48,331 0 | 48,331 | Form 4 |
| Hewes L. Becker CHIEF MEDICAL OFFICER | 2024-03-11 18:29:00 | 46,281 0 | 46,281 | Form 4 |
| Boral Anthony L. Chief Medical Officer | 2020-12-16 16:03:37 | 35,630 0 | 35,630 | Form 4 |
| Lee Philina CHIEF COMMERCIAL OFFICER | 2024-03-15 16:47:12 | 34,729 0 | 34,729 | Form 4 |
| Murray Christopher K. CHIEF TECHNICAL OPERATIONS | 2024-03-11 18:24:10 | 33,853 0 | 33,853 | Form 4 |
| Goldberg Mark Alan Director | 2023-06-23 19:06:48 | 21,312 0 | 21,312 | Form 4 |
| Hurley Ariel PRINCIPAL ACCOUNTING OFFICER | 2024-03-19 16:48:44 | 16,513 0 | 16,513 | Form 4 |
| COATS LONNEL Director | 2023-06-23 19:04:06 | 16,312 0 | 16,312 | Form 4 |
| Seely Lynn Director | 2023-06-23 19:06:17 | 16,312 0 | 16,312 | Form 4 |
| Beckman Daniella Director | 2023-06-23 19:00:31 | 13,900 0 | 13,900 | Form 4 |
| Demetri George Director | 2022-06-30 21:53:27 | 13,712 0 | 13,712 | Form 4 |
| Dable Habib J Director | 2023-06-23 19:04:53 | 11,800 0 | 11,800 | Form 4 |
| Tsai John Director | 2023-06-23 19:05:31 | 11,800 0 | 11,800 | Form 4 |
| Tango Therapeutics Inc. Director | 2021-12-10 16:25:29 | 10,400 0 | 10,400 | Form 4 |
| Rowland Charles A Jr Director | 2021-06-04 16:16:55 | 10,312 0 | 10,312 | Form 4 |